New Report In-Situ Hybridization Market 2023 : Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Leica Biosystems Nussloch GmbH and Others are Top Key Players

In-situ hybridization utilizes a labeled probe of complementary RNA, DNA, or modified nucleic acid to localize particular DNA or RNA sequence. In addition, in-situ hybridization indicates the localization of gene expression in their cellular environment. The two types of in situ hybridization namely fluorescence in situ hybridization (FISH), and chromogenic in situ hybridization (CISH) are used to identify the position of genes, which offer useful insights regarding tumors. The major drivers that fuel the growth of the market are increase in cancer prevalence, rise in awareness about cancer along with technology advancements in cancer therapeutics, and increase in government initiatives. In contrast, availability of better technologies, such as high-throughput whole genome sequencing and microarray, and others restrain the growth of the global in-situ hybridization market.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2893?utm_source=OPR

This report segments the global in situ hybridization market based on technique, application, end user, and region. Based on technique, it is categorized into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). Based on application, it is classified into cancer diagnosis, immunology, neuroscience, cytology, and infectious diseases. Based on end user, it is bifurcated molecular diagnostic laboratories, pharmaceutical & biotechnology companies, contract research organizations (CROS), and academic & research institutions. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players of the in-situ hybridization market are Abbott Laboratories, Inc., F. Hoffmann-La Roche AG, Leica Biosystems Nussloch GmbH, Agilent Technologies, Thermo Fisher Scientific, Inc., Merck KGaA, PerkinElmer, Inc., Exiqon A/S, BioGenex Laboratories, Inc., Advanced Cell Diagnostics, Inc., and Bio SB Inc.

Key Benefits of this Study:

• The study provides an in-depth analysis of the global in situ hybridization market, with current trends and future estimations to elucidate the imminent investment pockets.
• It presents a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities.
• Extensive analysis of the market by product type assists in understanding the various forms of in situ hybridization available.
• Key players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/2893?utm_source=OPR

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.